Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (DRKS00041517) titled 'Burden of Treatment in Children with Hereditary Angioedema and Their Caregivers' on Sept. 4.

Study Type: observational

Study Design: Allocation: Masking: Control: Assignment: Study design purpose: supportive care

Primary Sponsor: KalVista Pharmaceuticals Limited

Condition: D84.1 Defects in the complement system

Intervention: Group 1: Children with HAE and their caregivers are asked once using questionnaires developed for the study about the burden of treatment

Recruitment Status: Not Recruiting

Date of First Enrollment: 30/09/2026

Target Sample Size: 140

Countries of Recruitment: Germany

To know more,...